Share This

$945K NSF grant for CCNY's David Jeruzalmi

David Jeruzalmi, Jillian Chase, and Silas Harley in the Structural Biology Center
David Jeruzalmi, JillianChase and Silas Harley

As scientists have learned from working on diseases like HIV and tuberculosis, sometimes the best way to develop a new therapy is to think about how it might work in combination with other therapies. In order to do that, it’s important to identify, visualize, and modify new targets so a disease can be attacked from multiple vantage points.

David Jeruzalmi, professor of chemistry and biochemistry in The City College College of New York's Center for Discovery and Innovation, and his team have identified and visualized a three-dimensional model of a new target and a helicase protein that can modify it – opening and closing it (like a vault) at the origin of DNA replication.

The National Science Foundation has issued a $945,000 grant to fund the project as well as four years of follow-on studies related to the helicase protein. The project is entitled "Molecular Mechanisms of Bacterial Helicase Assembly and Activation at a Replication Origin."

Jeruzalmi’s team is one of the only groups working on this particular new target. So their ability to visualize the target and how the protein can modify it could provide a new potentially powerful arrow with which to attack the target.

Two doctoral students, Jillian Chase and Silas Harley, are contributing to the research.  “The award owes a lot to the New York Structural Biology Center, an independent facility on CCNY’s south campus which houses a large collection of electron microscopes, and excellent personnel to assist in their use. We couldn’t have gotten this far without ready access to this unique resource,” said Jeruzalmi.

It's estimated that 95% of the new drugs approved in the last 16 years were highly correlated with being able to visualize the 3-dimensional structure of the target. This means that scientists who use Jeruzalmi’s basic research in the future to help them develop new drugs could have an increased chance of approval.

About The City College of New York 
Since 1847, The City College of New York has provided a high quality and affordable education to generations of New Yorkers in a wide variety of disciplines. Today The Chronicle of Higher Education ranks CCNY #2 among public colleges with the greatest success in ensuring the social mobility of our student body; at the same time the Center for world University Rankings places it in the top 1.2% of universities worldwide in terms of academic excellence. More than 16,000 students pursue undergraduate and graduate degrees in eight professional schools and divisions, driven by significant funded research, creativity and scholarship. CCNY is as diverse, dynamic and visionary as New York City itself.  View CCNY Media Kit.

 

« BACK TO NEWS

Media contact: Rebecca Rivera, rrivera1@ccny.cuny.edu